January 20, 2021
JANUARY 2021 Jordan Messler, MD, SFHM, FACP, Executive Director, Clinical Practice, Glytec 4 Predictions for Diabetes Management and Technology in 2021 The COVID-19 pandemic continues to put an unprecedented amount of strain on the entire healthcare sector, and the industry has responded by accelerating the ways innovation is developed and adopted. Health leaders have faced a generational challenge and the …
December 15, 2020
Glytec Publishes First COVID-19 Research to Study the ‘Opportunity Window’ for Treating Hospitalized Patients with Diabetes or Hyperglycemia New Research Published in Diabetes Care Journal Reveals 7x Mortality Risk for Non-ICU Patients with Severe Hyperglycemia After 2-3 Days, Indicating Need to Start Treatment on Admission WALTHAM, MASS. (December 15, 2020) – Glytec, the only provider of insulin management software across the …
December 1, 2020
Glytec Leads ADCES Webinar on Inpatient Glycemic Management During COVID-19 Live Session and Q&A on December 10 Features Case Studies from Diabetes Care and Education Specialists WALTHAM, MASS. (December 1, 2020) – Glytec, the only provider of insulin management software across the continuum of care, today announced it is partnering with the Association of Diabetes Care & Education Specialists (ADCES) to …
November 24, 2020
NOVEMBER 2020 Koren Thomas Diabetes Nurses: On the Frontlines of a Long-Term Pandemic Diabetes nurses work on the frontlines in the fight against an ongoing epidemic/pandemic that will continue to afflict over 13% of the US population long after COVID-19 recedes into the background. The diabetes pandemic has been mounting rapidly in the early 21st century. In 2003, 194 million adults worldwide between …
November 20, 2020
NOVEMBER 2020 DR. JORDAN MESSLER, MD, SFHM, FACP Why Now is the Time to Prioritize Inpatient Glycemic Management More than seven million COVID-19 cases have been recorded in the United States, with over 400,000 of those individuals requiring hospitalization. Unfortunately, it’s safe to assume another spike in cases and hospitalizations are forthcoming this winter, with many states already seeing an …
November 17, 2020
Sarasota Memorial Health Care System Chooses Glytec to Enhance Diabetes Care Insulin Management Software Supports System-Wide Glycemic Best Practices with a Personalized Approach to Dosing that Prioritizes Patient Safety WALTHAM, MASS. (November 17, 2020) – Glytec, the only provider of insulin management software across the continuum of care, today announced that Sarasota Memorial Health Care System (SMH) selected its eGlycemic Management …
October 27, 2020
OCTOBER 2020 Insulin Titration Software Combined with CGM Enables Patients with Diabetes to Improve Time in Range First study to utilize CGM data with FDA-cleared, cloud-based titration software suggests significantly improved outcomes for patients while optimizing clinical resources This past summer, Glytec published the first proof-of-concept study that combines FDA-cleared remote insulin titration software and data from continuous glucose monitoring …
October 7, 2020
SEPTEMBER 2020 DR. JORDAN MESSLER, MD, SFHM, FACP Is Glucometrics The Missing Data in the Fight Against COVID-19? Glucometrics – the system-wide analysis of inpatient glucose data – should be of fundamental interest for hospital administrators striving to improve the outcomes of their patients. Why is this data so important? Proper glycemic control has been linked to improved outcomes and …
SEPTEMBER 2020 KEITH LORIA Are we there yet? A look at 4 value-based care programs The work of moving away from fee for service is in progress. The results so far? Mixed. Will COVID-19 accelerate or put the brakes on the move toward value-based payment? Christopher Chen, M.D., CEO of Miami-based ChenMed, says doctors will embrace value over volume as …
July 7, 2020
Glytec and ThunderCat Technology Partner to Improve Glycemic Management at VA Hospitals Collaboration Seeks to Improve Outcomes and Reduce Cost of Care for the 25% of Veterans with Diabetes WALTHAM, MASS. (July 7, 2020) – Glytec, the only provider of insulin management software across the continuum of care, and ThunderCat Technology, a Service-Disabled Veteran-Owned Small Business (SDVOSB) that delivers technology …
July 3, 2020
JULY 2020 JACQUELINE LISK Our health care system has holes. Data and AI can help us fix them Data and AI are transforming science and reducing health care costs. Moore’s Law states the speed and capabilities of computers will increase every couple of years, but their cost will continue to go down. John Sculley, a business leader, speaker, and author …
June 22, 2020
JUNE 2020 ELIZA SKOLER, JIMMY MCDERMOTT, MATTHEW GARZA, DIVYA GOPISETTY, FRIDA VELCANI, EMILY FITTS, KARENA YAN, JOSEPH BELL, LORENA BERGSTROM, AND ROSALIND LUCIER The Biggest News in Diabetes Technology, Drugs, and Nutrition: Highlights from ADA 2020 Insulin Management Software Glucommander Shows Positive Results on Time in Range An exciting study examined the success of the Glucommander insulin dosage software for …
June 16, 2020
JUNE 2020 ROBBY BOOTH 5 Reasons Why Providers Need Electronic Support for Glycemic Management It’s no secret hyperglycemia and hypoglycemia are associated with adverse outcomes in hospitalized patients. We’ve known for many years that hyperglycemia is widespread in the hospital, causes immune dysfunction, higher rates of infection, a longer length of hospital stay, complications, and even death. Insulin has been …
June 15, 2020
JUNE 2020 PATRICK CAMPBELL Bruce Bode, MD: Impact of COVID-19 on Diabetes Care and Endocrinology The impact of the coronavirus disease 2019 (COVID-19) outbreak on endocrinology has been impossible to ignore. With diabetic patients at increased risk of developing serious complications, endocrinologists have had to keep a keen eye on the latest on the disease for the wellbeing of their …
JUNE 2020 DAVE MUOIO Onduo, Medtronic, Abbott, Glytec present diabetes management study data at ADA 2020 virtual conference From virtual management programs to hybrid closed loop systems, diabetes management companies put the spotlight on improved blood glucose management and positive clinical outcomes. The American Diabetes Association’s 80th Scientific Sessions kicked off this weekend, and a handful of diabetes management device-makers …
Glytec’s Glucommander Software Combined with Continuous Glucose Monitoring Enables Patients with Diabetes to Improve Time in Range by More than 25% in Only Four Weeks First study to utilize CGM data with FDA-cleared, cloud-based titration software suggests significantly improved outcomes for patients while optimizing clinical resources WALTHAM, MASS. (June 16, 2020) – Glytec, the only provider of insulin management software across …
June 13, 2020
JUNE 2020 PATRICK CAMPBELL Preventing Hypoglycemia, Hyperglycemia with Insulin and Glucagon Coadministration Attempting to prevent hypoglycemia without worsening hyperglycemia in those with type 1 diabetes has been a challenge for clinicians for decades, but results of a new study from the American Diabetes Association’s (ADA) 80th Scientific Sessions signal there could be a change on the horizon. Results of the 11-person proof-of-concept trial …
June 11, 2020
Healthcare Providers Showcase Value of Glytec’s Insulin Management Software During Diabetes Technology Society’s Virtual Hospital Poster Session Event Includes Six Studies on Quality and Cost Improvements Achieved Through Glytec eGMS® WALTHAM, MASS. (June 11, 2020) – Glytec, the only provider of insulin management software across the continuum of care, announced today that healthcare providers from five separate health systems will present studies …
June 4, 2020
MAY 2020 DEREK BAGLEY Pandemic Parallels: Glycemic Control in COVID-19 Patients As the COVID-19 pandemic continues to roil the world’s healthcare systems, endocrinologists may have unique insights that could save lives and improve outcomes in these patients who present with elevated glucose levels and other underlying comorbidities such as obesity and diabetes. At a Glance Patients with diabetes who contract …
April 27, 2020
APRIL 27, 2020 Eleanor McDermid Uncontrolled hyperglycemia might be COVID-19 mortality risk factor medwireNews: A descriptive analysis of US patients with COVID-19 reports a high in-hospital mortality rate in those with uncontrolled hyperglycemia. The rate was markedly higher than that seen in patients with confirmed diabetes, although Valerie Garrett (Glytec Inc., Waltham, Massachusetts, USA) and co-researchers note that they did …
